Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) - Total Liabilities

Latest as of June 2025: CN¥222.24 Million CNY ≈ $32.52 Million USD

Based on the latest financial reports, Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) has total liabilities worth CN¥222.24 Million CNY (≈ $32.52 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of Shandong Keyuan Pharmaceutical Co. Ltd. to assess how effectively this company generates cash.

Shandong Keyuan Pharmaceutical Co. Ltd. A - Total Liabilities Trend (2021–2024)

This chart illustrates how Shandong Keyuan Pharmaceutical Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. Check Shandong Keyuan Pharmaceutical Co. Ltd. (301281) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Shandong Keyuan Pharmaceutical Co. Ltd. A Competitors by Total Liabilities

The table below lists competitors of Shandong Keyuan Pharmaceutical Co. Ltd. A ranked by their total liabilities.

Company	Country	Total Liabilities
Forum Energy Technologies Inc NYSE:FET	USA	$472.78 Million
Royce Micro Cap Closed Fund NYSE:RMT	USA	$20.93 Million
Matas A/S CO:MATAS	Denmark	Dkr5.90 Billion
CorMedix Inc NASDAQ:CRMD	USA	$376.73 Million
ChinaEtek Service & Technology Co. Ltd. SHE:301208	China	CN¥344.38 Million
Beijing Tongyizhong New Material Technology Corp SHG:688722	China	CN¥501.82 Million
TPI POLENE POWER BK:TPIPP-R	Thailand	฿31.03 Billion

Liability Composition Analysis (2021–2024)

This chart breaks down Shandong Keyuan Pharmaceutical Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Shandong Keyuan Pharmaceutical Co. Ltd. .

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	6.55	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.16	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.14	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shandong Keyuan Pharmaceutical Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shandong Keyuan Pharmaceutical Co. Ltd. A (2021–2024)

The table below shows the annual total liabilities of Shandong Keyuan Pharmaceutical Co. Ltd. A from 2021 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥192.87 Million ≈ $28.22 Million	+38.83%
2023-12-31	CN¥138.93 Million ≈ $20.33 Million	+5.20%
2022-12-31	CN¥132.06 Million ≈ $19.32 Million	+2.75%
2021-12-31	CN¥128.52 Million ≈ $18.81 Million	--

About Shandong Keyuan Pharmaceutical Co. Ltd. A

SHE:301281 China Drug Manufacturers - General

Market Cap

$597.24 Million

CN¥4.08 Billion CNY

Market Cap Rank

#11630 Global

#3551 in China

Share Price

CN¥37.69

Change (1 day)

-0.53%

52-Week Range

CN¥26.26 - CN¥50.45

All Time High

CN¥59.70